trail for Hypertension

Evaluation of antihypertensive effect of herbomineral drug- A randomised controlled comparative open clinical trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/054981

Enrollment

Registered

2023-07-10

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed hypertension patients. 2. K/c/o hypertension with or without antihypertensive drugs. (With or without symptoms). 3. Patients with: Stage 1 hypertension SBP (140-159)/DBP (90-99) mm of Hg

Exclusion criteria

Exclusion criteria: 1. Acute haemorrhagic condition, Acute septic shock 2. K/c/o hypertension history more than 12 years. 3. Hypertensive emergency i.e. blood pressure more than 180/120mm of Hg. 4. Secondary hypertension. 5. Pregnancy-induced hypertension. 6. Pregnant and lactating women. 7. IHD

Design outcomes

Primary

Measure	Time frame
Helps in reduction of blood pressure and sign and symptoms of hypertensionTimepoint: After 1 month	—

Secondary

Measure	Time frame
Improvement in lipid metabolism along with increase quality of life & complication of disease reduceTimepoint: 1 Month	—

Countries

India

Contacts

Public ContactDr.Nisha Munishwar

Parul Institute of Ayurved

nisha.munishwar8@gmail.com9130642840

Outcome results